Madrigal Pharmaceuticals (MDGL) Inventory Average (2024 - 2026)

Madrigal Pharmaceuticals (MDGL) has reported Inventory Average for 3 consecutive years, with $105.7 million the latest figure, recorded in Q2 2026.

• In Q2 2026, Inventory Average rose 78.09% year-over-year to $105.7 million; the TTM figure through Jun 2026 stood at $105.7 million (up 78.09% YoY), while the FY2025 annual figure was $54.5 million, changed N/A from the prior year.
• Inventory Average improved to $105.7 million in Q2 2026 per MDGL's latest filing, from $93.5 million in the prior quarter.
• Across five years, Inventory Average topped out at $105.7 million in Q2 2026 and bottomed at $4.0 million in Q2 2024.
• Historically, Inventory Average has averaged $52.8 million across 3 years, with a median of $59.4 million in 2025.
• Annual changes were most pronounced in 2025 — Inventory Average surged 1398.08% — and 2026, when it jumped 78.09%.
• Madrigal Pharmaceuticals' Inventory Average stood at $21.4 million in 2024, then soared by 236.95% to $72.1 million in 2025, then jumped by 46.69% to $105.7 million in 2026.
• Business Quant data shows MDGL's Inventory Average at $105.7 million in Q2 2026, $93.5 million in Q1 2026, and $72.1 million in Q4 2025.